XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
11 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ (13,845) $ 15,849,072
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Investment income earned on investments held in Trust Account 0 (284,779)
Offering costs associated with warrants recorded as liabilities 0 1,677,518
Change in fair value of warrant liabilities 0 (23,703,427)
Excess of fair value over cost on sale of Private Placement Warrants 0 2,146,129
Changes in operating assets and liabilities    
Prepaid expenses 0 (536,382)
Accrued expenses 0 3,391,416
Accrued expenses - related party 0 46,900
Payment of formation costs through issuance of Class B ordinary shares 13,845 0
Net cash used in operating activities 0 (1,413,553)
Cash flows from investing activities:    
Cash deposited in Trust Account 0 (1,000,000,000)
Net cash used in investing activities 0 (1,000,000,000)
Cash flows from financing activities:    
Proceeds received from initial public offering, gross 0 1,000,000,000
Proceeds received from sale of Private Placement Warrants 0 23,000,000
Payment of underwriter commissions 0 (20,000,000)
Payment of offering costs 0 (836,937)
Net cash provided by financing activities 0 1,002,163,063
Net change in cash 0 749,510
Cash – beginning of period 0 0
Cash – end of period 0 749,510
Supplemental disclosure of non-cash activities    
Deferred offering costs included in accrued offering costs 364,935 0
Accrued offering costs 0 85,000
Formation and offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 25,000 0
Deferred offering costs paid by the Sponsor through promissory note 147,385 0
Deferred underwriter’s commissions in connection with the initial public offering $ 0 $ 35,000,000